Ryan Cohlhepp, Pharm.D., is a distinguished pharmaceutical executive who currently holds the position of President and Chief Operating Officer at BICARA THERAPEUTICS INC. With an extensive background in the biopharmaceutical industry, Dr. Cohlhepp has demonstrated a profound ability to lead and innovate within the sector. He earned his Doctor of Pharmacy degree from the University of Pittsburgh, where he developed a strong foundation in pharmacology and patient care. His career trajectory showcases a consistent pattern of leadership roles in companies focused on developing novel therapies for complex diseases. Prior to joining BICARA THERAPEUTICS INC., Dr. Cohlhepp held several key positions that have shaped his expertise and strategic vision. Notably, he served as the Chief Operating Officer at TESARO, where he played a pivotal role in the company's growth and the successful launch of groundbreaking oncology treatments. His leadership was instrumental in navigating the company through the complexities of clinical development and regulatory approval processes. Dr. Cohlhepp's tenure at TESARO highlighted his capability to drive operational excellence and foster a culture of innovation, which are critical attributes he brings to his current role at BICARA. As President and Chief Operating Officer at BICARA THERAPEUTICS INC., Dr. Cohlhepp is responsible for overseeing the company's overall operations and strategic direction. His leadership is focused on advancing BICARA's pipeline of bi-specific therapies aimed at treating cancer and other serious diseases. Under his guidance, the company is poised to make significant strides in clinical development and bring transformative treatments to patients in need. Dr. Cohlhepp's dedication to improving patient outcomes and his strategic acumen continue to drive BICARA's mission forward, cementing his reputation as a visionary leader in the biopharmaceutical industry.